SEARCH

SEARCH BY CITATION

LITERATURE CITED

  • 1
    Cairo MS, Wagner JE. Placental and/or umbilical cord blood: an alternative source of hematopoietic stem cells for transplantation. Blood 1997; 90: 46654678.
  • 2
    Rubinstein P, Carrier C, Scaradavou A, Kurtzberg J, Adamson J, Migliaccio AR, Berkowitz RL, Cabbad M, Dobrila NL, Taylor PE, Rosenfield RE, Stevens CE. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 1998; 339: 15651577.
  • 3
    Gluckman E. Current status of umbilical cord blood hematopoietic stem cell transplantation. Exp Hematol 2000; 28: 11971205.
  • 4
    Sutherland DR, Keating A, Nayar R, Anania S, Stewart AK. Sensitive detection and enumeration of CD34+ cells in peripheral and cord blood by flow cytometry. Exp Hematol 1994; 22: 10031010.
  • 5
    Gratama JW, Orfao A, Barnett D, Brando B, Huber A, Janossy G, Johnsen HE, Keeney M, Marti GE, Preijers F, Rothe G, Serke S, Sutherland DR, Van Der Schoot CE, Schmitz G, Papa S. Flow cytometric enumeration of CD34+ hematopietic stem and progenitor cells. Cytometry 1998; 34: 128142.
  • 6
    Brando B, Barnett D, Janossy G, Mandy F, Autran B, Rothe G, Scarpati B, D'Avanzo G, D'Hautcourt J-L, Lenkei R, Schmitz G, Kunkl A, Chianese R, Papa S, Gratama JW. Cytofluorometric methods for assessing absolute numbers of cell subsets in blood. Cytometry 2000; 42: 327346.
  • 7
    Keeney M, Sutherland DR. Stem cell enumeration by flow cytometry: current concepts and recent developments in CD34+ cell enumeration. Cytotherapy 2000; 2: 395402.
  • 8
    Sutherland DR, Anderson L, Keeney M, Nayar R, Chin-Yee I. The ISHAGE guidelines for CD34+ cell determination by flow cytometry. J Hematother 1996; 5: 213226.
  • 9
    McNiece I, Kern B, Zilm K, Brunaud C, Dziem G, Briddell R. Minimization of CD34+ cell enumeration variability using the ProCOUNT standardized methodology. J Hematother 1998; 7: 499504.
  • 10
    Sims LC, Brecher ME, Gertis K, Jenkins A, Nickischer D, Schmitz JL, Sparks S, Wright P, Bentley S. Enumeration of CD34-positive stem cells: evaluation and comparison of three methods. J Hematother 1997; 6: 213226.
  • 11
    Gutensohn K, Carrero I, Krueger W, Kroeger N, Schäfer P, Luedemann K, Kuehnl P. Semi-automated flow cytometric analysis of CD34-expressing hematopoietic cells in peripheral blood progenitor cell apheresis products. Transfusion 1999; 39: 12201226.
  • 12
    Barbosa IL, Sousa ME, Godinho MI, Carvalhais A. Single- versus dual-platform assays for human CD34+ cell enumeration. Cytometry 1999; 38: 274279.
  • 13
    Hübl W, Iturraspe J, Martinez GA, Hutcheson CE, Roberts CG, Fisk DD, Sugrue MW, Wingard JR, Braylan RC. Measurement of absolute concentration and viability of CD34+ cells in cord blood and cord blood products using fluorescent beads and cyanine nucleic acid dyes. Cytometry 1998; 34: 121127.
  • 14
    Fornas O, Garcia J, Petriz J. Flow cytometry of CD34+ cells in whole blood. Nature Med 2000; 6: 833836.
  • 15
    Keeney M, Chin-Yee I, Weir K, Popma J, Nayar R, Sutherland DR. Single platform flow cytometric absolute CD34+ cell counts based on the ISHAGE guidelines. Cytometry 1998; 34: 6170.
  • 16
    Barnett D, Granger V, Kraan J, Whitby L, Reilly JT, Papa S, Gratama JW. Reduction of intra- and interlaboratory variation in CD34+ stem cell enumeration using a stable test material, standard protocols and targeted training. Br J Haematol 2000; 108: 784792.
  • 17
    Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1: 307310.
  • 18
    Chang A, Ma DDF. The influence of flow cytometric gating strategy on the standardization of CD34+ cell quantitation: an Australian multicenter study. J Hematother 1996; 5: 605616.
  • 19
    Bossuyt X, Marti GE, Fleisher TA. Comparative analysis of whole blood lysis methods for flow cytometry. Cytometry 1997; 30: 124133.
  • 20
    Cassens U, Gutensohn K, Garritsen H, Kelsch R, Kuehnl P, Sibrowski W. The influence of different erythrocyte lysing procedures on flow cytometric determination of CD34+ cells in umbilical cord blood transplants. Transfusion Med 1998; 8: 111118.
  • 21
    Serke S, van Lessen A, Pardo I, Huhn D. Selective susceptibility of CD34-expressing cells to acquire flow cytometric features of apoptosis/necrosis on exposure to an ammonium chloride-based red blood cell lysing reagent. J Hematother 1998; 7: 315318.
  • 22
    Menéndez P, Redondo O, Rodriguez A, Lopez-Berges MC, Ercilla G, López A, Durán A, Almeida J, Pérez-Simón JA, San Miguel JF, Gratama JW, Orfao A. Comparison between a lyse-and-then-wash method and a lyse-non-wash technique for the enumeration of CD34+ hematopoietic progenitor cells. Cytometry 1998; 34: 264271.
  • 23
    Keeney M, Chin-Yee I, Nayar R, Sutherland DR. Effect of fixatives on CD34+ cell enumeration. J Hematother Stem Cell Res 1999; 8: 327329.
  • 24
    Gratama JW, Menéndez P, Kraan J, Orfao A. Loss of CD34+ hematopoietic progenitor cells due to washing can be reduced by the use of fixative-free erythrocyte lysing reagents. J Immunol Methods 2000; 239: 1323.
  • 25
    Mifsud NA, Wall DM, Sparrow RL. An automated cell counter compared with flow cytometry for obtaining accurate leukocyte and lymphocyte subset estimations. Transfusion Med 1998; 8: 157.
  • 26
    Brando B, Göhde W Jr, Scarpati B, D'Avanzo G. The “vanishing counting bead” phenomenon: effect on absolute CD34+ cell counting in phosphate-buffered saline-diluted leukapheresis samples. Cytometry 2001; 43: 154160.